FC24: Evolving Therapies in the Treatment of Chronic Spontaneous Urticaria: An Online Activity

Evolving Therapies in the Treatment of Chronic Spontaneous Urticaria: An Online Activity
This activity is supported by educational grants from Genentech, a member of the Roche Group, Novartis Pharmaceuticals Corporation, and Sanofi and Regeneron Pharmaceuticals, Inc.